Summary
A series of approaches were tested in order to develop a simple technique for introducing a routine positive control into the Human Tumor Clonogenic Assay. Of the various techniques tested, the best proved to be the addition of the toxic plant lectin abrin to the culture system. When added to the agar underlayer of the culture system so that the final abrin concentration in culture was 10 μg/ml, survival of human tumor colonyforming units (TCFU) was reduced to <1% of control in 16/34 (47%) of human tumors, to < 10% in 33/34 (97%) and to <30% in all tumors tested (100%). A clear dose-response relationship to fractional survival was observed for individual tumors tested at multiple dose levels of abrin. When the dosage of abrin was reduced to 1 μg/ml, survival of TCFU was reduced to <30% in 25/28 (89.2%) of experiments. Inclusion of abrin controls in clonogenic assays thus provides an excellent and reproducible positive control to which cytotoxic effects of a variety of therapeutic agents can be compared.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197:461–463, 1977
Salmon SE (ed.): Cloning of Human Tumor Stem Cells. Alan R. Liss, Inc., New York, 1980, 388 pp
Salmon SE, Hamburger AW, Soehnlen B, Durie BGM, Alberts DS, Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. New Engl J Med 298:1321–1327, 1978
Alberts DS, Chen HSG, Soehnlen B, Salmon SE, Surwit EA, Young L, Moon TE: In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet: 340 (August), 1980
Salmon SE, Liu R, Casazza AM: Evaluation of new anthracycline analogs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6:103–110, 1981
Salmon SE, Durie, BGM, Young L, Liu R, Trown PW, Stebbing N: Effects of cloned human leukocyte interferons in the human tumor stem cell assay. J Clin Oncol 1(3):217–225, 1983
Von Hoff DD, Casper J, Bradley Ed, Sandbach J, Jones D, Makuch R: Association between human tumor colonyforming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 70:1027–1032, 1981
Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien MT, Casper, JT, Mattox DE, Page CP, Cruz AB, Sandbach JF: Prospective clinical trial of a human tumor cloning system. Cancer Res 43:1926–1931, 1983
Salmon SE: Application of the human tumor stem cell assay to new drug evaluation and screening. In: SE Salmon (ed): Cloning of Human Tumor Stem Cells. Alan R. Liss, Inc., New York, 1980, pp 291–312
Salmon SE: Application of the human tumor stem cell assay in the development of anticancer therapy. In: Burchenal and Oettgen (eds): Cancer: Achievements, Challenges and Prospects for the 1980's, Vol. 2. Grune and Stratton, New York, 1980, pp 33–43
Shoemaker RH, Wolpert-DeFilippes MK, Makuch RW, Venditti JM: Use of the human tumor clonogenic assay for new drug screening. Proc Amer Assoc Cancer Res 24:311, 1983 (Abstract)
Kressner BE, Morton RRA, Martens AE, Salmon SE, Von Hoff DD, Soehnlen B: Use of an image analysis system to count colonies in stem cell assays of human tumors. In: SE Salmon (eds): Cloning of Human Tumor Stem Cells. Alan R. Liss, Inc., New York, 1980, pp 179–196
Olsnes S, Refsnes K, Pihl A: Mechanism of action of the toxic lectins abrin and ricin. Nature 249:627, 1974
Lin CT, Tsai S, Lin YY, Tung TC, Lin WSJ: Studies of abrin toxic action on tumor cells by immunoelectron microscopy. J Ultrastruct Res 73:310–317, 1980
Sandvig K, Olsnes S: Entry of the toxic proteins abrin, modeccin, ricin and dipththeria toxin into cells. J Biol Chem 257(13):7495–7503, 1982
Olsnes S, Pihl A: Chimeric toxins. Pharmacol Ther 15:355–381, 1982
Tveit, KM, Fodstad O, Pihl A: The usefulness of human tumor cell lines in the study of chemosensitivity. A study of malignant melanomas. Int J Cancer 28:403–408, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salmon, S.E., Liu, R., Hayes, C. et al. Usefulness of abrin as a positive control for the human tumor clonogenic assay. Invest New Drugs 1, 277–281 (1983). https://doi.org/10.1007/BF00177410
Issue Date:
DOI: https://doi.org/10.1007/BF00177410